Literature DB >> 20724724

The fifteen years of discoveries that shaped molecular electrophysiology: time for appraisal.

Silvia G Priori1.   

Abstract

This article serves as an introductory overview to a thematic review series that will present the latest advancements in the field of inherited arrhythmias. This area of cardiac electrophysiology started approximately 15 years ago thanks to the contribution of Mark Keating and coworkers, who discovered the molecular basis of long QT syndrome. The field rapidly expanded when clinicians, molecular biologists, geneticists, and cellular electrophysiologists, who undertook an impressive collaborative effort to clarify the genetic basis of "cardiac channelopathies." As a result of this hard work, the paradigms for diagnosis and management of patients with inherited arrhythmogenic diseases were substantially modified, demonstrating once more the value of "translational research." As more and more genes have been implicated in the genesis of inherited arrhythmias, we keep broadening our understanding of the complexity of ion channels and their multifaceted regulatory processes. Despite the fact that several discoveries have already been made, the field is facing new challenges that are attracting young investigators who share with the pioneers the ambitious goal of finding new therapies and even a cure for these conditions.

Entities:  

Mesh:

Year:  2010        PMID: 20724724     DOI: 10.1161/CIRCRESAHA.110.226811

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  TBX5 drives Scn5a expression to regulate cardiac conduction system function.

Authors:  David E Arnolds; Fang Liu; John P Fahrenbach; Gene H Kim; Kurt J Schillinger; Scott Smemo; Elizabeth M McNally; Marcelo A Nobrega; Vickas V Patel; Ivan P Moskowitz
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 2.  Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death.

Authors:  Hugues Abriel; Jean-Sébastien Rougier; José Jalife
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

3.  Models of excitation-contraction coupling in cardiac ventricular myocytes.

Authors:  M Saleet Jafri
Journal:  Methods Mol Biol       Date:  2012

Review 4.  Mechanisms of ventricular arrhythmias: a dynamical systems-based perspective.

Authors:  Elizabeth M Cherry; Flavio H Fenton; Robert F Gilmour
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-30       Impact factor: 4.733

5.  Ca2+/calmodulin-dependent protein kinase II-based regulation of voltage-gated Na+ channel in cardiac disease.

Authors:  Olha M Koval; Jedidiah S Snyder; Roseanne M Wolf; Ryan E Pavlovicz; Patric Glynn; Jerry Curran; Nicholas D Leymaster; Wen Dun; Patrick J Wright; Natalia Cardona; Lan Qian; Colleen C Mitchell; Penelope A Boyden; Philip F Binkley; Chenglong Li; Mark E Anderson; Peter J Mohler; Thomas J Hund
Journal:  Circulation       Date:  2012-09-24       Impact factor: 29.690

6.  Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.

Authors:  Atara Novak; Avraham Lorber; Joseph Itskovitz-Eldor; Ofer Binah
Journal:  Rambam Maimonides Med J       Date:  2012-07-31

7.  A mechanistic description of gating of the human cardiac ryanodine receptor in a regulated minimal environment.

Authors:  Saptarshi Mukherjee; N Lowri Thomas; Alan J Williams
Journal:  J Gen Physiol       Date:  2012-07-16       Impact factor: 4.086

8.  Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation.

Authors:  Atara Novak; Lili Barad; Naama Zeevi-Levin; Revital Shick; Ronit Shtrichman; Avraham Lorber; Joseph Itskovitz-Eldor; Ofer Binah
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

Review 9.  Inherited arrhythmia syndrome predisposing to sudden cardiac death.

Authors:  Yun Gi Kim; Suk-Kyu Oh; Ha Young Choi; Jong-Il Choi
Journal:  Korean J Intern Med       Date:  2021-03-26       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.